LIDCO GROUP PLC 
By Press Release | 14 July 2011 |
LIDCO GROUP PLC
("LiDCO" or the "Company")
LiDCO signs agreement with ICU Medical, Inc
LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, today announces that it has signed an agreement with ICU Medical, Inc. of San Clemente, California, USA ("ICU Medical") appointing LiDCO as a non exclusive distributor of complementary ICU Medical products in the UK. This will add to the third party products that LiDCO can offer to its UK customers.
In addition the two companies signed a non exclusive licensing agreement providing ICU Medical access to some of LiDCO's intellectual property (IP) rights. Under the terms of the agreement, LiDCO will receive an up front payment and royalties on any future sales derived from the IP.
ICU Medical develops, manufacturers and sells innovative medical technologies used by hospitals in acute care settings.
Dr Terry O'Brien, CEO of LiDCO stated "We are delighted to sign this agreement with ICU Medical. These arrangements will complement our third party offering to customers in the UK and adds to our growing base of corporate partners."
-Ends-
For further information, please contact:
LiDCO Group Plc | |
Terry O'Brien (CEO) | Tel: +44 (0)20 7749 1500 |
Paul Clifford (Finance Director) | |
John Rowland (Company Secretary) | www.lidco.com |
FinnCap | |
Geoff Nash / Henrik Persson Stephen Norcross (broking) | Tel: +44 (0)20 7600 1658 www.finncap.com |
Media enquiries:
Abchurch | |
Sarah Hollins / Joanne Shears / Simone Elviss / Jamie Hooper | Tel: +44 (0) 20 7398 7728 |
simone.elviss@abchurch-group.com |
About LiDCO Group Plc
LiDCO is a supplier of minimally invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimization protocols for high risk patients in both critical care units and in the operating theatre.
